ResearcherKagoshima UniversityNo recent work listed
Yumi Miyazaki
Matched on OpenAlex author ID A5102279353. Sources: OpenAlex.
Their work
- Papers
- 8 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 8
2012: 2 papers · 2013: 1 paper · 2014: 1 paper · 2015: 1 paper · 2016: 3 papers
Papers 8
- miR-30 family promotes migratory and invasive abilities in CD133(+) pancreatic cancer stem-like cells. Co-author DOI 10.1007/s13577-016-0137-7↗
- Efficient elimination of pancreatic cancer stem cells by hedgehog/GLI inhibitor GANT61 in combination with mTOR inhibition. Co-author DOI 10.1186/s12943-016-0534-2↗
- CD133 Modulate HIF-1α Expression under Hypoxia in EMT Phenotype Pancreatic Cancer Stem-Like Cells. Co-author DOI 10.3390/ijms17071025↗
- Slug contributes to gemcitabine resistance through epithelial-mesenchymal transition in CD133(+) pancreatic cancer cells. Co-author DOI 10.1007/s13577-015-0117-3↗
- CD133 facilitates epithelial-mesenchymal transition through interaction with the ERK pathway in pancreatic cancer metastasis. First author DOI 10.1186/1476-4598-13-15↗
- mTOR plays critical roles in pancreatic cancer stem cells through specific and stemness-related functions. Co-author DOI 10.1038/srep03230↗
- Establishment of a highly migratory subclone reveals that CD133 contributes to migration and invasion through epithelial-mesenchymal transition in pancreatic c… Co-author DOI 10.1007/s13577-011-0037-9↗
- Interferon-alpha modulates the chemosensitivity of CD133-expressing pancreatic cancer cells to gemcitabine. Co-author DOI 10.1111/j.1349-7006.2012.02235.x↗
Closest collaborators
The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Sonshin Takao · 8 shared papers, 2012–2016 · strength 0.41
- Paper miR-30 family promotes migratory and invasive abilities in CD133(+) pancreatic cancer stem-like cells. DOI 10.1007/s13577-016-0137-7↗
- Paper Efficient elimination of pancreatic cancer stem cells by hedgehog/GLI inhibitor GANT61 in combination with mTOR inhibit… DOI 10.1186/s12943-016-0534-2↗
- Paper Slug contributes to gemcitabine resistance through epithelial-mesenchymal transition in CD133(+) pancreatic cancer cell… DOI 10.1007/s13577-015-0117-3↗
- Qiang Ding · 8 shared papers, 2012–2016 · strength 0.41
- Paper miR-30 family promotes migratory and invasive abilities in CD133(+) pancreatic cancer stem-like cells. DOI 10.1007/s13577-016-0137-7↗
- Paper Efficient elimination of pancreatic cancer stem cells by hedgehog/GLI inhibitor GANT61 in combination with mTOR inhibit… DOI 10.1186/s12943-016-0534-2↗
- Paper Slug contributes to gemcitabine resistance through epithelial-mesenchymal transition in CD133(+) pancreatic cancer cell… DOI 10.1007/s13577-015-0117-3↗
- Koichiro Tsukasa · 6 shared papers, 2013–2016 · strength 0.35
- Paper miR-30 family promotes migratory and invasive abilities in CD133(+) pancreatic cancer stem-like cells. DOI 10.1007/s13577-016-0137-7↗
- Paper Efficient elimination of pancreatic cancer stem cells by hedgehog/GLI inhibitor GANT61 in combination with mTOR inhibit… DOI 10.1186/s12943-016-0534-2↗
- Paper Slug contributes to gemcitabine resistance through epithelial-mesenchymal transition in CD133(+) pancreatic cancer cell… DOI 10.1007/s13577-015-0117-3↗
- Shyuichiro Matsubara · 5 shared papers, 2012–2016 · strength 0.25
- Paper miR-30 family promotes migratory and invasive abilities in CD133(+) pancreatic cancer stem-like cells. DOI 10.1007/s13577-016-0137-7↗
- Paper Slug contributes to gemcitabine resistance through epithelial-mesenchymal transition in CD133(+) pancreatic cancer cell… DOI 10.1007/s13577-015-0117-3↗
- Paper CD133 facilitates epithelial-mesenchymal transition through interaction with the ERK pathway in pancreatic cancer metas… DOI 10.1186/1476-4598-13-15↗
- Shoji Natsugoe · 4 shared papers, 2012–2016 · strength 0.19
- Paper miR-30 family promotes migratory and invasive abilities in CD133(+) pancreatic cancer stem-like cells. DOI 10.1007/s13577-016-0137-7↗
- Paper CD133 Modulate HIF-1α Expression under Hypoxia in EMT Phenotype Pancreatic Cancer Stem-Like Cells. DOI 10.3390/ijms17071025↗
- Paper Interferon-alpha modulates the chemosensitivity of CD133-expressing pancreatic cancer cells to gemcitabine. DOI 10.1111/j.1349-7006.2012.02235.x↗
- Koki Maeda · 3 shared papers, 2012–2016 · strength 0.12
- Paper CD133 Modulate HIF-1α Expression under Hypoxia in EMT Phenotype Pancreatic Cancer Stem-Like Cells. DOI 10.3390/ijms17071025↗
- Paper Interferon-alpha modulates the chemosensitivity of CD133-expressing pancreatic cancer cells to gemcitabine. DOI 10.1111/j.1349-7006.2012.02235.x↗
- Paper Establishment of a highly migratory subclone reveals that CD133 contributes to migration and invasion through epithelia… DOI 10.1007/s13577-011-0037-9↗
- Tomomi Hayashi · 3 shared papers, 2012–2016 · strength 0.12
- Paper CD133 Modulate HIF-1α Expression under Hypoxia in EMT Phenotype Pancreatic Cancer Stem-Like Cells. DOI 10.3390/ijms17071025↗
- Paper Interferon-alpha modulates the chemosensitivity of CD133-expressing pancreatic cancer cells to gemcitabine. DOI 10.1111/j.1349-7006.2012.02235.x↗
- Paper Establishment of a highly migratory subclone reveals that CD133 contributes to migration and invasion through epithelia… DOI 10.1007/s13577-011-0037-9↗
- Hiroyuki Shinchi · 1 shared paper, 2016 · strength 0.06
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.